Farina Antonio, Cavoretto Paolo I, Syngelaki Argyro, Adjahou Stephen, Nicolaides Kypros H
Obstetric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Department of Obstetrics and Gynecology, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Am J Obstet Gynecol. 2025 Apr;232(4):392.e1-392.e14. doi: 10.1016/j.ajog.2024.08.025. Epub 2024 Aug 23.
Previous evidence showed that placental dysfunction triggers spontaneous preterm or term births and intrapartum fetal compromise and often requires urgent delivery, thereby exposing both the fetus and the mother to significant risks. Predicting spontaneous labor onset and intrapartum fetal compromise could improve obstetrical management and outcomes, but this is currently difficult, particularly in low-risk populations.
The objective of this study was to examine whether placental dysfunction, as assessed at 36 weeks' gestation by the soluble fms-like tyrosine kinase-1 to placental growth factor ratio, is associated with the interval to spontaneous onset of labor and intrapartum fetal compromise that requires cesarean delivery in a routinely examined population.
This was a retrospective analysis of prospectively collected data of women with singleton pregnancies who underwent routine assessment at 35+0 to 36+6 weeks' gestation at the King's College Hospital (London, England). Using a general linear model, the study examined the outcomes related to the soluble fms-like tyrosine kinase-1/placental growth factor ratio, including the time interval from testing to spontaneous onset of labor and the subsequent rate of fetal compromise that required a cesarean delivery. Patients who underwent induction of labor or prelabor cesarean deliveries were excluded from the study. Competing risks regression and Cox regression models were used to estimate the cumulative incidence and the risk of the outcomes of interest.
In the screened population of 45,375 patients, 23,831 (52.5%) had spontaneous onset of labor and were included in the analysis. Cases with an soluble fms-like tyrosine kinase-1/placental growth factor ratio >50 delivered about 1 week earlier than those with a ratio of ≤50 (39.2 vs 40.0 weeks' gestation; P<.001). The general linear model showed that a larger soluble fms-like tyrosine kinase-1/placental growth factor ratio was associated with earlier spontaneous onset of labor (P<.001), particularly among multiparous women. The soluble fms-like tyrosine kinase-1/placental growth factor ratio was significantly associated, as expected, with cases of preeclampsia and advanced maternal age. The cumulative incidence of spontaneous onset of labor was significantly higher in cases with an soluble fms-like tyrosine kinase-1/placental growth factor ratio >50 than in those with a ratio 50 (P<.001). Cox regression showed that the risk for spontaneous onset of labor increased with an soluble fms-like tyrosine kinase-1/placental growth factor ratio >50 (hazard ratio, 1.424; 95% confidence interval, 1.253-1.618; P<.001) and, as expected, the risk was mitigated over time from when the soluble fms-like tyrosine kinase-1/placental growth factor ratio was measured to spontaneous labor onset (P<.001). Cases with intrapartum fetal compromise had a higher mean soluble fms-like tyrosine kinase-1/placental growth factor ratio than those without intrapartum fetal compromise (21.79 vs 17.67; P<.001). Qualitative addition of fetal compromise to the general linear model showed a higher soluble fms-like tyrosine kinase-1/placental growth factor ratio in cases with fetal compromise than in those without fetal compromise (P=.014). Competing risks regression showed a positive dose-response effect for fetal compromise with increasing soluble fms-like tyrosine kinase-1/placental growth factor ratios (P<.001). Above and below the optimal cutoff of 50, the quoted cumulative incidences were 6.7% and 4.7%, respectively (P<.001). The effect of the soluble fms-like tyrosine kinase-1/placental growth factor ratio remained significant even after adjusting for preeclampsia, which is a well-known major risk factor for fetal compromise. Finally, the proportion of cases with intrapartum fetal compromise who had an soluble fms-like tyrosine kinase-1/placental growth factor ratio >50 decreased from 35% to 0% with advancing gestation.
This study showed that an increased soluble fms-like tyrosine kinase-1/placental growth factor ratio at 36 weeks' gestation is associated with an earlier gestational age at spontaneous onset of labor and higher rates of intrapartum fetal compromise. There are 2 major implications, namely an soluble fms-like tyrosine kinase-1/placental growth factor ratio >50 indicates imminent labor onset with about a 40% mean risk increase and immediate clinical translation for term pregnancy monitoring. In addition, an increased soluble fms-like tyrosine kinase-1/placental growth factor ratio increases the risk for intrapartum fetal compromise, although outcome variability indicates reassessment within multimarker models.
先前的证据表明,胎盘功能障碍会引发自发性早产或足月分娩以及产时胎儿窘迫,且常常需要紧急分娩,从而使胎儿和母亲都面临重大风险。预测自发性临产和产时胎儿窘迫可改善产科管理及结局,但目前这颇具难度,尤其是在低风险人群中。
本研究的目的是探讨在常规检查人群中,孕36周时通过可溶性fms样酪氨酸激酶-1与胎盘生长因子的比值评估的胎盘功能障碍,是否与自发性临产间隔时间以及需要剖宫产的产时胎儿窘迫相关。
这是一项对前瞻性收集的单胎妊娠女性数据的回顾性分析,这些女性在英国伦敦国王学院医院于孕35⁺⁰至36⁺⁶周进行了常规评估。该研究使用一般线性模型,检验了与可溶性fms样酪氨酸激酶-1/胎盘生长因子比值相关的结局,包括从检测到自发性临产的时间间隔以及随后需要剖宫产的胎儿窘迫发生率。接受引产或临产前剖宫产的患者被排除在研究之外。使用竞争风险回归和Cox回归模型来估计累积发生率和感兴趣结局的风险。
在筛查的45375例患者中,23831例(52.5%)发生了自发性临产并纳入分析。可溶性fms样酪氨酸激酶-1/胎盘生长因子比值>50的病例比比值≤50的病例提前约1周分娩(妊娠周数分别为39.2周和40.0周;P<0.001)。一般线性模型显示,较高的可溶性fms样酪氨酸激酶-1/胎盘生长因子比值与较早的自发性临产相关(P<0.001),尤其是在经产妇中。正如预期的那样,可溶性fms样酪氨酸激酶-1/胎盘生长因子比值与子痫前期病例和高龄产妇显著相关。可溶性fms样酪氨酸激酶-1/胎盘生长因子比值>50的病例中自发性临产的累积发生率显著高于比值≤50的病例(P<0.001)。Cox回归显示,可溶性fms样酪氨酸激酶-1/胎盘生长因子比值>50时,自发性临产的风险增加(风险比,1.424;95%置信区间,1.253 - 1.618;P<0.001),并且正如预期的那样,从测量可溶性fms样酪氨酸激酶-1/胎盘生长因子比值到自发性临产,随着时间推移风险降低(P<0.001)。产时发生胎儿窘迫的病例的平均可溶性fms样酪氨酸激酶-1/胎盘生长因子比值高于未发生产时胎儿窘迫的病例(分别为21.79和17.67;P<0.001)。在一般线性模型中定性加入胎儿窘迫因素后显示,发生胎儿窘迫的病例的可溶性fms样酪氨酸激酶-1/胎盘生长因子比值高于未发生胎儿窘迫的病例(P = 0.014)。竞争风险回归显示,随着可溶性fms样酪氨酸激酶-1/胎盘生长因子比值升高,胎儿窘迫存在正性剂量反应效应(P<0.001)。在最佳临界值50之上和之下,所述累积发生率分别为6.7%和4.7%(P<0.001)。即使在调整子痫前期(这是胎儿窘迫的一个众所周知的主要危险因素)后,可溶性fms样酪氨酸激酶-1/胎盘生长因子比值的影响仍然显著。最后,随着孕周增加,产时发生胎儿窘迫且可溶性fms样酪氨酸激酶-1/胎盘生长因子比值>50的病例比例从35%降至0%。
本研究表明,孕36周时可溶性fms样酪氨酸激酶-1/胎盘生长因子比值升高与自发性临产时较早的孕周以及产时胎儿窘迫的较高发生率相关。有两个主要意义,即可溶性fms样酪氨酸激酶-1/胎盘生长因子比值>50表明即将临产,平均风险增加约40%,并且可立即用于足月妊娠监测的临床转化。此外,可溶性fms样酪氨酸激酶-1/胎盘生长因子比值升高会增加产时胎儿窘迫的风险,尽管结局的变异性表明需要在多标记模型中进行重新评估。